Airline Travel Notices
For more COVID-19 travel restrictions please see the US Department of State website.
For up to date COVID-19 travel restrictions for Chile travel please see the US Embassy-Chile webpage.
Are U.S. citizens permitted to enter? No. Only Chilean citizens and foreign residents of Chile may enter
Is a negative COVID-19 test (PCR and/or serology) required for entry? Yes. The test must be taken within 72 hours of boarding the final flight to Chile. The 72-hour time period begins from the time the test is administered, not from the time that results are returned. Only PCR tests for COVID-19 are acceptable for entry into Chile “rapid” or “antigen only” tests will not be accepted
Are health screening procedures in place at airports and other ports of entry? Yes
Beginning April 5, Chilean citizens and residents of Chile will be required to request a permit from the Comisaría Virtual in order to depart Chile. The government of Chile has informed that such permits will be granted only in exceptional circumstances. Non-resident foreigners continue to be allowed to depart Chile. Virtual. Non-resident foreigners will not be allowed to enter Chile, but will be allowed to depart.
All passengers (including Chileans and residents) must complete an obligatory 10-day quarantine upon arrival in Chile. The first 5 days of quarantine will be conducted at a “transit hotel” designated by the Chilean Ministry of Health. During this 5-day period, all passengers will be required to take a second PCR test. If the test returns negative, passengers will be allowed to spend the second 5-day period of quarantine in their residence or a hotel of their choice. Passengers who test positive will be taken to a “sanitary residence” to complete their quarantine there. Passengers are responsible for the cost of the initial five-day stay in the “transit hotel”.
Travelers (of all ages) will have to present three documents when boarding:
A completed “Affidavit of Travelers” electronic form (available at www.c19.cl and also known as a Sanitary Passport) prepared less than 48 hours before boarding;
Proof of a negative result from a PCR result from a test taken within 72 hours prior to boarding their final flight to Chile. (Note: the 72-hour time period begins from the time the test is administered – not from when the test results are returned); and
Proof of a health insurance policy that provides coverage for Covid-19 and related health issues during the traveler’s stay in Chile. The Health Insurance must cover charges associated with COVID-19 during your stay, with a coverage of USD $ 30,000 (minimum). All documents must be presented before boarding the flight to Chile.
“Rapid” COVID-19 tests (for example, antigen-only tests) are not accepted for entry into Chile. The test must be a PCR test for SARS-CoV-2 (COVID-19).
Foreign residents of Chile and holders of diplomatic/official passports are exempt from the health insurance requirements.
U.S. citizens should contact the Policía de Investigaciones (PDI) for information regarding the extension of tourist or resident visas
Financial support for Rubin Observatory comes from the National Science Foundation (NSF) through Cooperative Agreement No. 1258333, the Department of Energy (DOE) Office of Science under Contract No. DE-AC02-76SF00515, and private funding raised by the LSST Corporation. The NSF-funded Rubin Observatory Project Office for construction was established as an operating center under management of the Association of Universities for Research in Astronomy (AURA). The DOE-funded effort to build the the Rubin Observatory LSST Camera (LSSTCam) is managed by the SLAC National Accelerator Laboratory (SLAC).
The National Science Foundation (NSF) is an independent federal agency created by Congress in 1950 to promote the progress of science. NSF supports basic research and people to create knowledge that transforms the future.
NSF and DOE will continue to support Rubin Observatory in its Operations phase. They will also provide support for scientific research with LSST data.
Contact | Employment | LSST Corporation